References
- JemalASiegelRWardEMurrayTXuJThunMJCancer statistics, 2007CA Cancer J Clin2007571436617237035
- ArgirisAKaramouzisMVRabenDFerrisRLHead and neck cancerLancet200837196251695170918486742
- BrizelDMEsclamadoRConcurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrumJ Clin Oncol200624172612261716763273
- MendenhallWMAmdurRJPaltaJRIntensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfallsJ Clin Oncol200624172618262316763274
- MaloufJGAragonCHensonBSEisbruchAShipJAInfluence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patientsCancer Detect Prev200327430531012893079
- ChaoKSDeasyJOMarkmanJA prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial resultsInt J Radiat Oncol Biol Phys200149490791611240231
- MünterMWKargerCPHoffnerSGEvaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphyInt J Radiat Oncol Biol Phys200458117518414697436
- JabbariSKimHMFengMMatched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial reportInt J Radiat Oncol Biol Phys200563372573116199308
- NguyenNPChiABetzMFeasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancerPLoS ONE201278e4272922916151
- LefebvreJLRollandFTesselaarMEORTC Head and Neck Cancer Cooperative GroupEORTC Radiation Oncology GroupPhase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapyJ Natl Cancer Inst2009101314215219176454
- JensenADKraussJWeichertWDisease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)Radiat Oncol2011612221942981
- KatoriHTsukudaMWataiKComparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)Cancer Chemother Pharmacol200760339940617096160
- BusatoIMIgnácioSABrancherJAMoysésSTAzevedo-AlanisLRImpact of clinical status and salivary conditions on xerostomia and oral health-related quality of life of adolescents with type 1 diabetes mellitusCommunity Dent Oral Epidemiol2012401626921883355
- ChenAMFarwellDGLuuQVazquezEGLauDHPurdyJAIntensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancerInt J Radiat Oncol Biol Phys201284117017522300572
- TribiusSBergeltCIntensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain?Cancer Treat Rev201137751151921324605
- WuBMcNuttTZahurakMFully automated simultaneous integrated boosted-intensity modulated radiation therapy treatment planning is feasible for head-and-neck cancer: a prospective clinical studyInt J Radiat Oncol Biol Phys2012845e647e65322867890
- VlacichGDiazRThorpeSWIntensity-modulated radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer: toxicities and efficacyOncologist201217567368122550060
- YaoMDornfeldKJBuattiJMIntensity-modulated radiation treatment for head-and-neck squamous cell carcinoma – the University of Iowa experienceInt J Radiat Oncol Biol Phys200563241042116168834
- MaguirePDPapagikosMHamannSPhase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancerInt J Radiat Oncol Biol Phys20117941081108820378262
- HablGJensenADPotthoffKTreatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocolBMC Cancer20101065121108850
- YaoMLuMSavvidesPSDistant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapyInt J Radiat Oncol Biol Phys201283268468922169673
- NguyenNPVockJVinh-HungVEffectiveness of prophylactic retropharyngeal lymph node irradiation in patients with locally advanced head and neck cancerBMC Cancer20121225322708791
- PignonJPle MaîtreABourhisJMACH-NC Collaborative GroupMeta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an updateInt J Radiat Oncol Biol Phys200769Suppl 2S112S11417848275
- PignonJPle MaîtreAMaillardEBourhisJMACH-NC Collaborative GroupMeta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patientsRadiother Oncol200992141419446902
- MontejoMEShrieveDCBentzBGIMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neckInt J Radiat Oncol Biol Phys2011815e845e85221167654
- TongCCLauKHRiveraMPrognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapyOncol Rep20122751580158622322320
- GuptaTAgarwalJJainSThree-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trialRadiother Oncol2012104334334822853852
- MendenhallWMMendenhallCMMendenhallNPSubmandibular Gland-sparing Intensity-modulated RadiotherapyAm J Clin Oncol Epub2012813
- O’SullivanBRumbleRBWardePMembers of the IMRT Indications Expert PanelIntensity-modulated radiotherapy in the treatment of head and neck cancerClin Oncol (R Coll Radiol)201224747448722770590